StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Realco S.A.
Brussels Stock Exchange:REAL.BR
Sector
Location
Market Cap
USD 11.15 M
Share Price
USD 17.33
Avg Daily Volume
22
Change (1 day)
-0.53%
Change (1 year)
Change (YTD)
21.54%
Realco S.A. Net Income for the year ending December 31, 2024: USD 273.22 K
Realco S.A. Net Income is USD 273.22 K for the year ending December 31, 2024, a -4.56% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
Realco S.A. Net Income for the year ending December 31, 2023 was USD 286.28 K, a 116.48% change year over year.
-
Realco S.A. Net Income for the year ending December 31, 2022 was USD 132.24 K, a -94.30% change year over year.
-
Realco S.A. Net Income for the year ending December 31, 2021 was USD 2.32 M, a -2.11% change year over year.
-
Realco S.A. Net Income for the year ending December 31, 2020 was USD 2.37 M, a 449.39% change year over year.
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Lonza Group AG
USD 696.77
LONN.SW
-1.24
-0.18%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Ucb S.A.
USD 199.43
UCB.BR
+0.52
0.26%
Hansoh Pharmaceutical Group Company Limited
USD 4.00
3692.HK
+0.10
2.47%
Insmed Incorporated
USD 96.14
INSM
-0.81
-0.83%
Summit Therapeutics Inc.
USD 22.99
SMMT
+0.38
1.68%
Torrent Pharmaceuticals Limited
USD 38.73
TORNTPHARM.NS
-0.02
-0.05%
Key Data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) |
|---|
Competitors
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Lonza Group AG
USD 696.77
LONN.SW
-1.24
-0.18%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Ucb S.A.
USD 199.43
UCB.BR
+0.52
0.26%
Hansoh Pharmaceutical Group Company Limited
USD 4.00
3692.HK
+0.10
2.47%
Insmed Incorporated
USD 96.14
INSM
-0.81
-0.83%
Summit Therapeutics Inc.
USD 22.99
SMMT
+0.38
1.68%
Torrent Pharmaceuticals Limited
USD 38.73
TORNTPHARM.NS
-0.02
-0.05%